Kathryn Garner

Principal Scientist at Newcells Biotech

Kathryn is Head of Kidney Development and is pioneering the first glomerular model at Newcells. In 2017, Kathryn was awarded a prestigious Kidney Research UK Intermediate Fellowship, which enabled her to use her extensive experience in High Content Screening (HCS) to explore the effect of high blood pressure and inflammation on kidney podocytes.

Kathryn earned a first-class honours degree in Molecular Cell Biology from UCL in 2008 and a PhD from the same department four years later.

From here, she moved to the University of Bristol to carry out her post-doctoral research. Joining the group of Professor Craig McArdle in 2014, training in high content imaging and working alongside computer scientists to develop mathematical models of Gonadotropin releasing hormone signalling. Kathryn joined Professor Richard Coward’s group in Bristol Renal in 2016, beginning her journey in renal research funded by Takeda Cambridge Ltd to develop a high throughput assay for ER stress in diabetic nephropathy.


Org chart

Timeline

  • Principal Scientist

    Current role